Diane Cope
Nurse Practitioner · Fort Myers, FLNPI 1124322649
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,272 of the $3,664 with a category attached, or 89.3%. It is spread thinly across 41 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$426
- Johnson & Johnson$424
- Gilead$311
- E.r. Squibb & Sons, L.L.C.$227
- Novartis$187
- Lilly USA, LLC$169
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,27289%
- Education$39211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $426 |
| Johnson & Johnson | 14 | $424 |
| Gilead | 15 | $311 |
| E.r. Squibb & Sons, L.L.C. | 13 | $227 |
| Novartis | 9 | $187 |
| Lilly USA, LLC | 4 | $169 |
| Bristol Myers Squibb | 6 | $149 |
| Springworks Therapeutics, Inc. | 2 | $148 |
| Daiichi Sankyo Inc. | 6 | $135 |
| AbbVie | 6 | $134 |
| Genentech, Inc. | 2 | $134 |
| Merck | 5 | $124 |
| Seagen Inc. | 2 | $103 |
| Sobi, Inc | 6 | $101 |
| Incyte Corporation | 5 | $95 |
| Beigene USA, Inc. | 4 | $78 |
| Beone Medicines USA, Inc. | 3 | $75 |
| AstraZeneca | 3 | $67 |
| Mirati Therapeutics, Inc. | 2 | $43 |
| Sanofi | 2 | $37 |
| Recordati_rare_diseases_inc. | 1 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $33 |
| Array Biopharma Inc | 2 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $31 |
| Boehringer Ingelheim | 1 | $30 |
| Iovance Biotherapeutics, Inc. | 1 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| Taiho Oncology, Inc. | 2 | $27 |
| Astellas Pharma US Inc | 2 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| BD | 1 | $21 |
| Bayer | 1 | $16 |
| Amgen | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,664 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $277 |
| Oxycodone Hcl | 20 | $136 |
| Tramadol Hcl | 24 | $111 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fort Myers
- Laura TaylorFort Myers$27K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.